PNPLA3 I148M variant links to adverse metabolic traits in MASLD during fasting and feeding

The <i>PNPLA3</i> rs738409 (p.I148M) polymorphism is the most prevalent genetic risk factor for metabolic dysfunction-associated steatotic liver disease progression and is influenced by fasting and feeding cycles. However, the pathophysiological consequences of this regulation remain poorly understood. Nuclear magnetic resonance-proteometabolomics reveals a distinct signature in homozygous <i>PNPLA3</i> GG carriers that changes significantly with fasting status, providing important implications for diagnosis and preventive strategies.

Authors

Institutions

Publication Details

Journal
JHEP Reports
Published
2025-05-10
DOI
https://doi.org/10.1016/j.jhepr.2025.101450
Citations
4
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
5.42

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

PNPLA3 I148M variant links to adverse metabolic traits in MASLD during fasting and feeding

Bandik Föh, Monika Rau, Friedhelm Sayk, Marcin Krawczyk et al.
4 citations
JHEP Reports
Liver Disease Diagnosis and Treatment
5.42
article

PNPLA3 I148M variant links to adverse metabolic traits in MASLD during fasting and feeding

Bandik Föh, Monika Rau, Friedhelm Sayk, Marcin Krawczyk, Andrea Schenk, Sebastian M. Meyhöfer, Andreas Geier, Darko Castven, Ulrich L. Günther, Álvaro Mallagaray, Susanne N. Weber, Lorena Rudolph, Lina Jegodzinski, Ashok K. Rout, Jörn M. Schattenberg, Laura Hölzen, Jens U. Marquardt, Svenja Meyhöfer
article en
4 citations

Abstract

The <i>PNPLA3</i> rs738409 (p.I148M) polymorphism is the most prevalent genetic risk factor for metabolic dysfunction-associated steatotic liver disease progression and is influenced by fasting and feeding cycles. However, the pathophysiological consequences of this regulation remain poorly understood. Nuclear magnetic resonance-proteometabolomics reveals a distinct signature in homozygous <i>PNPLA3</i> GG carriers that changes significantly with fasting status, providing important implications for diagnosis and preventive strategies.

JHEP ReportsVol. 7(8)
Carl von Ossietzky Universität Oldenburg (DE), University Hospital Schleswig-Holstein (DE), Universitätsklinikum Würzburg (DE), Novo Nordisk (Germany) (DE), Deutsches Diabetes-Zentrum e.V. (DE), German Center for Diabetes Research (DE), Heinrich Heine University Düsseldorf (DE), University of Duisburg-Essen (DE), Saarland University (DE), University of Lübeck (DE)
Bundesministerium für Bildung und Forschung, Else Kröner-Fresenius-Stiftung, Universität zu Lübeck
Zero hunger
Openalex Percentile: Top 4%
Liver Disease Diagnosis and Treatment
5.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.